Glenview, IL- A study published in the February journal CHEST® suggests long-term inhaled corticosteroids (ICS) in patients with COPD may increase risk of bone fractures in both men and women. Previous studies have suggested that ICS negatively impacts bone mineral density in a dose-dependent fashion, particularly affecting postmenopausal women, but it has been unclear whether these effects translate to bone fractures.
Researchers from McGill University and the Jewish General Hospital-Lady Davis Research Institute used a population-based cohort of patients with COPD, aged 55 or older, that was followed for the occurrence of a hip or upper extremity fracture and found that long-term ICS exposure at high doses was associated with modest but significant increase in the risk of hip or upper extremity fractures.
Utilizing the Quebec health care databases, researchers formed a cohort of patients with COPD over 1990-2005, followed until 2007 for hip and upper extremity fractures. In addition, a nested case-control analysis was conducted in which each case of fracture was matched with 20 control subjects including: age, sex and follow-up time. The adjusted rate ratio of fracture with ICS usage was estimated using the conditional logistic regression with an interaction term to compare the risk in men and women.
Results showed that of the 240,110 patients with COPD in the cohort, 19,396 sustained a fracture during a mean 5.3 years (at a rate of 15.2 per 1,000 per year). The fracture rate was increased for those who used ICS longer than four years at daily doses of 1,000 mcg or more, equally so for male and female COPD patients.
"Since fractures are more frequent in women than men, our study suggests that the excess number of fractures associated with ICS will be greater in women even though we did not find that the risk increase was particularly higher in women than in men," said Dr. Samy Suissa, lead researcher. "Quantifying this excess number would require a larger cohort."
The complete study was published in the February issue of the journal CHEST®.
About the journal CHEST®
The journal CHEST®, the official publication of the American College of Chest Physicians®, features the best in peer-reviewed, cutting-edge original research in the multidisciplinary specialties of chest medicine: pulmonary, critical care and sleep medicine; thoracic surgery; cardiorespiratory interactions; and related disciplines. Published since 1935, it is home to the highly regarded clinical practice guidelines and consensus statements. Readers find the latest research posted in the Online First section each week and access series that provide insight into relevant clinical areas, such as Recent Advances in Chest Medicine; Topics in Practice Management; Pulmonary, Critical Care, and Sleep Pearls; Ultrasound Corner; Chest Imaging and Pathology for Clinicians; and Contemporary Reviews. Point/Counterpoint Editorials and the CHEST Podcasts address controversial issues, fostering discussion among physicians. Access the journal CHEST online at chestjournal.org.